Incyte announces European Commission approval of Minjuvi (tafasitamab)
Incyte announces European Commission approval of Minjuvi (t…
3 months ago
marketscreener.com
Anti-CD19 monoclonal antibodies for the treatment of DLBCL
25:57
Anti-CD19 monoclonal antibodies for the treatment of DLBCL
209 views9 months ago
YouTubeLymphoma Hub
Anti-CD19 monoclonal antibodies for the treatment of DLBCL
0:48
Anti-CD19 monoclonal antibodies for the treatment of DLBCL
383 views9 months ago
YouTubeLymphoma Hub
Dr. Burke on Research With Tafasitamab in Lymphoma
0:54
Dr. Burke on Research With Tafasitamab in Lymphoma
340 viewsMay 8, 2020
YouTubeOncLive
Tafasitamab: A New Horizon for Follicular Lymphoma Treatment | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
2:19
Tafasitamab: A New Horizon for Follicular Lymphoma Treatment | …
7 months ago
targetedonc.com
The role of tafasitamab in the lymphoma treatment landscape & promising results from clinical trials
1:30
The role of tafasitamab in the lymphoma treatment landscape & …
291 viewsJul 27, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Treatment of R/R DLBCL: CD19-Targeted Monoclonal Antibodies
4:46
Treatment of R/R DLBCL: CD19-Targeted Monoclonal Antibodies
52 viewsAug 13, 2020
YouTubeTargeted Oncology
Five-year Efficacy and Safety of Tafasitamab in Patients With Rela…
May 25, 2023
onclive.com
Dr. Flinn on Opportunities for Second-Line Tafasitamab in DLBC…
Jul 14, 2020
onclive.com
Tafasitamab Approaches EU Approval for Relapsed/Refractory …
4 months ago
onclive.com
Dr. Flinn on the Utility of Tafasitamab in Relapsed/Refractor…
Jun 12, 2020
onclive.com
2:25
The impact of tafasitamab on the efficacy and safety of CD19 CAR-…
136 viewsMay 10, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
Incyte obtient les droits exclusifs de développement et de commerciali…
Feb 5, 2024
zonebourse.com
Practical Considerations for Tafasitamab-R2 and Epcoritamab-…
3 months ago
onclive.com
3:58
Clinical Experience Using Tafasitamab Plus Lenalidomide in …
Feb 4, 2025
onclive.com
FDA Approves Tafasitamab Plus Lenalidomide and Rituximab for R…
9 months ago
onclive.com
3:12
Tafasitamab at the blood-brain barrier: exploring this agent for th…
448 viewsAug 1, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:57
Future Directions for R/R DLBCL
29 viewsAug 13, 2020
YouTubeTargeted Oncology
3:51
Real-World Outcomes of Tafasitamab-Lenalidomide for Pati…
Jan 29, 2024
onclive.com
Dr Mehta on the FDA Approval of Tafasitamab Plus Rituximab/Lenal…
9 months ago
onclive.com
3:00
Maggie shares her story about how her life has changed, her outlook f…
49 views4 months ago
FacebookMONJUVI® (tafasitamab-cxix)
7:33
MINJUVI (Tafasitamab): El Nuevo Paradigma en Inmunoterapia Dirig…
1 month ago
YouTubeUn Farmacéutico
Tafasitamab Lenalidomide Therapy in Relapsed/Refractory DLBCL | O…
Jun 26, 2023
onclive.com
Tafasitamab Lenalidomide vs. CIT for Transplant-Ineligible R/R DLBCL
354 viewsSep 30, 2024
vumedi.com
43:55
Developing Transformative Therapies for Patients with Diffus…
36 viewsFeb 4, 2021
YouTubeOnco'Zine - The International Oncology Network
6:37
L-MIND Trial in Relapsed/Refractory DLBCL
1.1K viewsFeb 25, 2020
YouTubeOncLive
2:02
The use of tafasitamab in DLBCL
442 viewsFeb 9, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:31
Please see the Full Prescribing Information, including Patient Info…
240.7K views5 months ago
FacebookMONJUVI® (tafasitamab-cxix)
13:39
How effective is the combination of tafasitamab and lenalidomide in tr…
249 viewsMar 31, 2025
YouTubeLymphoma Hub
See more videos
Static thumbnail place holder